Carboplatin (CBDCA, JM-8) and VP-16-213 in previously untreated patients with small-cell lung cancer.
JF Bishop, D Raghavan, R Stuart-Harris… - Journal of Clinical …, 1987 - ascopubs.org
The efficacy and toxicity of carboplatin 100 mg/m2, administered intravenously (IV) daily X 3,
and VP-16-213 120 mg/m2, IV daily X 3, administered every 28 days for six courses, was …
and VP-16-213 120 mg/m2, IV daily X 3, administered every 28 days for six courses, was …
Carboplatin (CBDCA, JM-8) and VP-16-213 in previously untreated patients with small-cell lung cancer
JF Bishop, D Raghavan… - Journal of clinical …, 1987 - pubmed.ncbi.nlm.nih.gov
The efficacy and toxicity of carboplatin 100 mg/m2, administered intravenously (IV) daily X 3,
and VP-16-213 120 mg/m2, IV daily X 3, administered every 28 days for six courses, was …
and VP-16-213 120 mg/m2, IV daily X 3, administered every 28 days for six courses, was …
Carboplatin (CBDCA, JM-8) and VP-16-213 in previously untreated patients with small-cell lung cancer
JF Bishop, D Raghavan… - Journal of Clinical …, 1987 - researchers.mq.edu.au
The efficacy and toxicity of carboplatin 100 mg/m 2, administered intravenously (IV) daily x 3,
and VP-16-213 120 mg/m 2, IV daily x 3, administered every 28 days for six courses, was …
and VP-16-213 120 mg/m 2, IV daily x 3, administered every 28 days for six courses, was …
[PDF][PDF] Carboplatin (CBDCA, JM-8) and VP-16–213 in Previously Untreated Patients With Small-Cell Lung Cancer
JF Bishop, D Raghavan, R Stuart-Harris… - Journal of Clinical …, 1987 - academia.edu
The efficacy and toxicity of carboplatin 100 mg/mº, administered intravenously (IV) daily X 3,
and VP-16–213 120 mg/m", IV daily x 3, administered every 28 days for six courses, was …
and VP-16–213 120 mg/m", IV daily x 3, administered every 28 days for six courses, was …
Carboplatin (CBDCA, JM-8) and VP-16-213 in previously untreated patients with small-cell lung cancer.
JF Bishop, D Raghavan, R Stuart-Harris… - Journal of Clinical …, 1987 - europepmc.org
The efficacy and toxicity of carboplatin 100 mg/m2, administered intravenously (IV) daily X 3,
and VP-16-213 120 mg/m2, IV daily X 3, administered every 28 days for six courses, was …
and VP-16-213 120 mg/m2, IV daily X 3, administered every 28 days for six courses, was …
[PDF][PDF] Carboplatin (CBDCA, JM-8) and VP-16–213 in Previously Untreated Patients With Small-Cell Lung Cancer
JF Bishop, D Raghavan, R Stuart-Harris… - Journal of Clinical …, 1987 - researchgate.net
The efficacy and toxicity of carboplatin 100 mg/mº, administered intravenously (IV) daily X 3,
and VP-16–213 120 mg/m", IV daily x 3, administered every 28 days for six courses, was …
and VP-16–213 120 mg/m", IV daily x 3, administered every 28 days for six courses, was …
[引用][C] Carboplatin (CBDCA, JM8) and VP-16-213 in previously untreated patients with small-cell lung cancer
JF BISHOP - J Clin Oncol, 1987 - cir.nii.ac.jp
Carboplatin(CBDCA,JM8)and VP-16-213 in previously untreated patients with small-cell
lung cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …
lung cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …
[引用][C] Carboplatin (CBDCA, JM-8) and VP-16-213 in previously untreated patients with small-cell lung cancer
B JF - J Clin Oncol., 1987 - cir.nii.ac.jp
Carboplatin (CBDCA, JM-8) and VP-16-213 in previously untreated patients with small-cell
lung cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
lung cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …